EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models

Wei-Chieh Huang, Lan-Hsin Shu, Yu-Ju Kuo, Kevin Shu-Leung Lai, Chih-Wei Hsia iD, Ting-Lin Yen iD, Chih-Hsuan Hsia, Thanasekaran Jayakumar, Chih-Hao Yang iD, Joen-Rong Sheu iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25042098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Wei-Chieh Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. Hauptthemen laut MEDLINE: Eugenol, Pulmonary Embolism. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council Taiwan, Taipei Medical University, Taipei Medical University-Taipei Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platelets assume a pivotal role in the pathogenesis of cardiovascular diseases (CVDs), emphasizing their significance in disease progression. Consequently, addressing CVDs necessitates a targeted approach focused on mitigating platelet activation. Eugenol, predominantly derived from clove oil, is recognized for its antibacterial, anticancer, and anti-inflammatory properties, rendering it a valuable medicinal agent. This investigation delves into the intricate mechanisms through which eugenol influences human platelets. At a low concentration of 2 μM, eugenol demonstrates inhibition of collagen and arachidonic acid (AA)-induced platelet aggregation. Notably, thrombin and U46619 remain unaffected by eugenol. Its modulatory effects extend to ATP release, P-selectin expression, and intracellular calcium levels ([Ca2+]i). Eugenol significantly inhibits various signaling cascades, including phospholipase Cγ2 (PLCγ2)/protein kinase C (PKC), phosphoinositide 3-kinase/Akt/glycogen synthase kinase-3β, mitogen-activated protein kinases, and cytosolic phospholipase A2 (cPLA2)/thromboxane A2 (TxA2) formation induced by collagen. Eugenol selectively inhibited cPLA2/TxA2 phosphorylation induced by AA, not affecting p38 MAPK. In ADP-treated mice, eugenol reduced occluded lung vessels by platelet thrombi without extending bleeding time. In conclusion, eugenol exerts a potent inhibitory effect on platelet activation, achieved through the inhibition of the PLCγ2–PKC and cPLA2-TxA2 cascade, consequently suppressing platelet aggregation. These findings underscore the potential therapeutic applications of eugenol in CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EugenolPulmonary EmbolismHumansMiceAnimalsPhospholipase C gammaPhosphatidylinositol 3-KinasesDisease Models, AnimalPlatelet ActivationPlatelet AggregationBlood PlateletsPhosphorylationProtein Kinase CThromboxane A2CollagenPhospholipases A2, Cytosolic

Stichwörter der Autor:innen

MAPKPI3K/Akt/GSK-3βPLCγ2–PKCcPLA2/TxA2eugenolhuman plateletspulmonary thrombosis

Substanzen

EugenolPhospholipase C gammaPhosphatidylinositol 3-KinasesProtein Kinase CThromboxane A2CollagenPhospholipases A2, Cytosolic

Autor:innen und Institutionen

  • Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
  • Graduate Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei 106, Taiwan.
  • Division of Critical Care Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
  • Department of Medical Research, Taipei Medical University Hospital, Taipei 110, Taiwan.
  • Department of Medical Research, Cathay General Hospital, Taipei 106, Taiwan.
  • Translational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, 111, Taiwan.

ORCID-Profile: Chih-Wei Hsia, Ting-Lin Yen, Chih-Hao Yang, Joen-Rong Sheu

Förderung

  • National Science and Technology Council Taiwan
  • Taipei Medical University
  • Taipei Medical University-Taipei Medical University Hospital
  • National Science and Technology Council

Zitieren

APA

Huang, W. C., Shu, L. H., Kuo, Y. J., Lai, K. S., Hsia, C. W., Yen, T. L., Hsia, C. H., Jayakumar, T., Yang, C. H., & Sheu, J. R. (2024). Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042098

Vancouver

Huang WC, Shu LH, Kuo YJ, Lai KS, Hsia CW, Yen TL, et al. Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042098

BibTeX
@article{Huang2024,
  author = {Huang, Wei-Chieh and Shu, Lan-Hsin and Kuo, Yu-Ju and Lai, Kevin Shu-Leung and Hsia, Chih-Wei and Yen, Ting-Lin and Hsia, Chih-Hsuan and Jayakumar, Thanasekaran and Yang, Chih-Hao and Sheu, Joen-Rong},
  title = {Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25042098}
}
Kostenlos starten →